Cardiovascular outcome trials for anti-diabetes medication: A holy grail of drug development?
about
Follow the LEADER-Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results Trial.Safety evaluation of trelagliptin in the treatment of Japanese type 2 diabetes mellitus patients.Glycemic equipoise.Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors' Expert Forum.Salutogenesis in Type 2 Diabetes Care: A Biopsychosocial Perspective.
P2860
Cardiovascular outcome trials for anti-diabetes medication: A holy grail of drug development?
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Cardiovascular outcome trials ...... oly grail of drug development?
@ast
Cardiovascular outcome trials ...... oly grail of drug development?
@en
Cardiovascular outcome trials ...... oly grail of drug development?
@nl
type
label
Cardiovascular outcome trials ...... oly grail of drug development?
@ast
Cardiovascular outcome trials ...... oly grail of drug development?
@en
Cardiovascular outcome trials ...... oly grail of drug development?
@nl
prefLabel
Cardiovascular outcome trials ...... oly grail of drug development?
@ast
Cardiovascular outcome trials ...... oly grail of drug development?
@en
Cardiovascular outcome trials ...... oly grail of drug development?
@nl
P2093
P2860
P3181
P1476
Cardiovascular outcome trials ...... oly grail of drug development?
@en
P2093
Ambika Gopalakrishnan Unnikrishnan
Mathew John
P2860
P304
P3181
P356
10.1016/J.IHJ.2016.02.017
P407
P50
P577
2016-01-01T00:00:00Z